Alcohol-Related Disorders, Alcohol Use Disorder (AUD), Substance-Related Disorders
Conditions
Keywords
activity tracker, alcohol use disorder, physical activity, treatment, mental health
Brief summary
The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder
Interventions
Fitbit Versa 3 is a commercially available activity tracker
In-patient alcohol use disorder treatment, including group therapy, counseling, and occupational activities
Sponsors
Study design
Eligibility
Inclusion criteria
* Being 18 years old or older. * Be undergoing inpatient treatment for alcohol use disorder.
Exclusion criteria
* Finishing the in-treatment before 4 weeks.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Physical activity tracker adherence | Treatment duration (4 weeks) | Days (percentage) in which activity tracker was used (day-time and night-time use) |
| Physical activity tracker perceived utility | End-of-treatment (4 weeks) | Perceived utility with the physical activity tracker will be assessed using ad-hoc questions about the utility of the activity tracker to increase levels of physical activity, improve sleep quality, and reduce/abandon tobacco. |
| Physical activity levels | In-treatment (4 weeks), from enrollment to end-of treatment (4 weeks) | Physical activity (PA) is operationalized as steps per day, plants climbed per day, distance covered per day (kilometers), light physical activity (minutes per day), moderate physical activity (minutes per week), vigorous physical activity (minutes per week), and sedentary time (hours per day). These outcomes will be measured using an adapted version of the International Physical Activity Questionnaire (IPAQ) and Fitbit Versa 3®. |
| Depression symptoms | From enrollment to the end-of-treatment (4 weeks) | Depression symptoms will be measured using the Patient Health Questionnaire-9 (PHQ-9). This questionnaire ranges from 0 to 14. A higher punctuation means higher depression symptom levels. |
| Anxiety symptoms | From enrollment to the end-of-treatment (4 weeks) | Anxiety symptoms will be measured using Generalized Anxiety Disorder-7 (GAD-7). This questionnaire ranges from 0 to 21. Higher punctuation means higher anxiety levels symptoms. |
| Difficulties in emotion regulation | From enrollment to the end-of-treatment (4 weeks) | Emotion dysregulation is measured using the Difficulties in Emotion Regulation Scale (DERS). Emotional dysregulation of negative emotions is measured with the Difficulties in Emotion Regulation Scale (DERS). This scale ranges from 28 to 140 points. A higher score means more difficulties in emotion regulation. |
| Physical activity tracker acceptability | End-of-treatment (4 weeks) | Acceptability of the activity tracker is measured using the Participant Experience Questionnaire (PEQ). This scale ranges from 10 to 50 points. A higher score means higher acceptability. |
| Sleep quality | In-treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks) | Sleep quality will be measured using both the Pittsburg Sleep Quality Index (PSQI) and the Fitbit Versa 3. PSQI ranges from 0 to 21 points. A higher score means lower sleep quality. In addition, Fitbit Versa 3 provides a sleep quality punctuation ranging from 0 to 100. A higher punctuation means better sleep quality. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Tobacco use | In treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks) | Self-reported cigarettes per day and carbon monoxide (CO) levels measured by a CO monitor reading. |
| Delay discounting (impulsive decision making) | From enrollment to the end-of-treatment (4 weeks) | Delay discounting will be measured using the 21-item Monetary-Choice task. Computerized Delay Discounting task of tobacco (delay of one day, one week, one month, and six months). |
Countries
Spain